Thus, inhibiting the DKK1-CKAP4 and MEK-ERK pathways simultaneously may provide a new strategy of the treatment for PDAC and ESCC expressing DKK1 and FOXM1. The gene discussed is CKAP4; the disease is esophageal squamous cell carcinoma.